MARY CARTER: Open Payments
NPI 1316409139 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 14 payments from 7 companies in 2025. Trend: 2023 $422 · 2024 $443 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Organon LLC | 2 | $37 |
| Astellas Pharma US Inc | 2 | $31 |
| Exeltis, USA Inc. | 1 | $16 |
| MILLICENT US INC | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $13 |
Products named: UBRELVY, Lynkuet, NEXPLANON, Veozah, QULIPTA, Mirena, SLYND, INTRAROSA.
Industry payments across VA — which companies pay providers there.
